-
CONTACTContact Information
- Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)
- Business Registration No.: 109-86-37282
- CEO: Choongseong Han
- Tel: +82-2-2088-8886
- Fax: +82-2-2088-8884
- E-mail: support@nexel.co.kr
-
- Home
- News
- News
News
Total 14
Bio Venture Company NEXEL Takes its First Step toward being Listed on KOSDAQ After Being Certified as a Company Specializing in Materials, Parts, and Equipment (MPE)
NEXEL earns Korean Industry Technology certification for So-Bu-Jang specialization from KEIT
NEXEL Earns the First ISO/IEC 17025:2017 Accreditation for iPSC-derived Cardiomyocyte-based Cardiac Safety Testing
Celogics highlights its iPSC derived Cardiomyocytes at the Society of Toxicology (SOT) Annual Meeting and Tox Expo
Celogics Licenses in NEXEL's Cardiosight-S for Global Distribution
Nexel, 'Chinese Patent Registration' for New Drug Candidate for NASH Fibrosis
Curi Bio and NEXEL Announce Celogics, Joint Venture to Develop Leading iPSC-derived Cell Products
NEXEL Co., Ltd. signed Strategic Business Partnership Agreement with Next&Bio
Korea Ministry of Food and Drug Safety Issues a Revised Guideline on Cardiac Safety Pharmacology
NEXEL Co., Ltd. raises USD 15.6 million in bridge round